Product Images Tivicay

This is a very brief and simple instruction telling someone to administer medicine to a child.*

This text is a simple instruction stating to administer medicine to an infant.*

This is a prescription medication called TivicayPD with the active ingredient dolutegravir. It is available in tablet form and is not interchangeable with other medications. Each tablet contains 5mg of dolutegravir, and the bottle comes with 60 tablets and a dosing syringe and cup. The medication should not be chewed, cut, or crushed, and should not be used if the membrane seal under the cap is missing or broken. The prescribing information should be consulted for dosing instructions.*

This is a prescription drug with the name Tivicay, whose active ingredient is dolutegravir. It comes in a film-coated tablet formulation with each tablet containing 10 mg of dolutegravir in the form of dolutegravir sodium. It is packed in a bottle containing 30 tablets and should be stored at controlled room temperature. The prescribing information should be consulted for dosage recommendations. The drug is marketed by ViiV Healthcare.*

This is a medication with the name "Ivica" (dolutegravir) which comes in film-coated tablet form with each tablet containing 25mg of dolutegravir sodium. It is a prescription medication with dosage information on the prescribing information. It should be stored at a controlled room temperature of 25°C, with excursions permitted at 10-30°C (59° to 86°F). The manufacturer is located in Research Triangle Park, NC 27709, and it is made in Japan.*

This is a prescription drug called Tivicay (dolutegravir) used for treating HIV. Each film-coated tablet contains dolutegravir sodium equivalent to 50 mg of dolutegravir. It comes in a bottle of 30 tablets and should be stored at a controlled room temperature of 25°C (77°F), with excursions permitted to 15°t0 30°C (59° to 86°F). The manufacturer is ViiV Healthcare based in Research Triangle Park, NC, and the medication is made in Japan. For dosage information, please refer to the prescribing information.*